Definitions, Tables, Facts - Renal And Endo Flashcards
KDIGO stage 1
Increase in creatnine by 26.5mmol/L
Or 1.5x baseline in 7 days
AND
U/O <0.5ml/kg/hr for 6 hours
KDIGO 2
Creatinine 2-2.9x baseline
U/O 0.5ml/kg/hr 12 hours
KDIGO 3
Creatinine 3x baseline OR Rise by 353.6 umol/litre OR Needing RRT
Urine output 0.3mls/kg/hr for 24 hours
OR
12 hours of anuria
Complications of AKI
Metabolic - acidosis, hyperkalaemia, electrtolytes, uraemic enceph
Fluid - tissue overload, resp failure, postive balance
Long term - progress to CKD, need for long term RRT
Risk factors for AKI
Known CKD CCF, DM, Liver disease Previous AKI Any impairment limiting access to fluids (neuro, cognitive) Age 65 Sepsis and hypovolaemia
NEPHROTOXIC DRUGS - ACEi, ARBS, Gent, diuretics, NSAIDs
Obstructions
Other causes - ?contrast
Rhabdo, HUS, TLS, GN, nephritis
Surgery - emergency, intraperitoneal
Summary of management with AKI
Initial resus
Assess fluid status
Replace with isotonic crystalloids
Haemodynamic support
Hx and Exam D&V - hypovol Bloody diarrhoea - HUS No urine - obstruction Haematuria - GN, stones, Ca Haemoptyiss - Wegeners, vasculitis Joint pain/rask - SLE
Ix - Urinalysis, protein, blood, micropscopy FBC, U&E, LFT, CRP, CK, Glucose, Ca, PO3, Mg, ANtibodies - ANCA, GBM, ANA (SLE) Renal US
Stages of CKD
1 >90 mls/min/1.73m2BSA 2 60-89 3 30- 59 (A 45-59, B 30-44) 4 15-29 5 <15
Prognositcally worse if proteinuria
Problems with CKD in ITU
PK -
Altered Vd
Decreased clearence
Decreased protein binding
Fluid/Electro Hyperparathyroidism Hyperphosphate Acidosis Hyperkalaemia Overload
CVS
Hyptertension
Risk of CVD
Haem
Anaemia
Uraemic plt dysfunction
Impaired immuno
Neuro- polyneuropathy
May need dialysis OR conversion from intermittant to continuous
Components of an RRT circuit
Extracorporeal circuit including semi permeable membrane
Blood pumps
Pressure sensors and air detectors/traps
Vascular access device
Anit-coaguation
Basic principles of RRT
HF - Convection
HD - Diffusion (solutes down a gradient)
HF - hydrostatic pressure gradient across a semi permeable membrane
solvent drag carries low weigh solutes with water —> ultrafiltrate
fluid replaces ultrasfiltrate —> determines net fluid
HD - Blood and diasylate fluid run countercurrent to each other seperated by a membrane
Solutes diffuse across
Fluid removed by increasing pressure
What are membranes made of
Cellulose or Semi synth
Celluose - low permeability, good for HD
Activate inflammation, less useful in critical illness
Semi-synth - high permeabiliry to water, less inflammation, both HF and HD
Thinner large area membrances —> more diffusion/convection
Indications for RRT
Ureamia - enceph, pericarditis, bleeding
Absolute urea above 36??
Hyperkalaemia
Met acidosis
Oligo-anuria
Fluid overload
Extra:
Volume removal, prevent overlaoad
?sepsis
Drugs in overdose
Types of RRT
Continuous or intermittant (usually IHD), or peritoneal
Continuous - HF, HD, HDF
Flows needed for CVVHF
100-200ml/min
Recommended dose
Effluent rate - 20-25mls/kg/hour
Types of anticoag in RRT
None Systemic —> UFH, LMWH UFH - can monitor and reverse Risk of HIT LMWH - Xa monitoring, but partially reversed only
CItrate - chelates calcium pre filter, therefore hypocalcaemia
Prostaglandins - inhibits platelets —> hypotension
FWD in hypernatraemia
= 0.6 x weight x ((current Na/Target Na)-1)
Causes of hypokalaemia
Low intake - eating disorders, nutrition, malignancy
Increased loss - GI (D&V), Renal loss Dieuretics, Conn’s, Cushings, liquorice RTA releated to amphoetricin B Osmotic diuresis with hyperglycama
Movement into cells Alkalosis Sympathetics - salbut Insulin Refeeding
ECG hypokalaemia
Prolonger PR Flat T wave Increased p wave amplitudfe U waves Apparent QT prolonged (QU)